Меню
КартаВръзкиТемиБългарияНощта (K-TRIO)Мария Склодовска-КюриЗа ученициЗа учителиМетодологияИзненадай ме
HEСъфинансиране2023–2027

BIOTIN · Biomedical Technologies and Innovation Doctoral Programme

„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“

Период
2023-01-01 → 2027-12-31
Финансиране от ЕС
1 344 000 €
Участници
29
Схема
HORIZON-TMA-MSCA-Cofund-D

Линиите свързват координатора с партньорите.

Накратко на български

Биомедицинските технологии обединяват науките за живота, инженерството и анализа на данни за създаване на нови приложения в медицината. Обучението на специалисти в тези области помага за по-бързото превръщане на научните открития в реални продукти и патенти.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Biomedical Technologies and Innovation Doctoral Programme

Despite the recent advances, there remains a significant gap between scientific discoveries and real-life applications in biomedical research. One of the main reasons that has been slowing down translation of academic discoveries in the biomedical field is the lack of qualified personnel having multidisciplinary technical skills endowed with transferrable skills. Biomedical Technologies and Innovation (BIOTIN) Doctoral Program aims to provide 10 doctoral candidates (DCs) a unique blend of research training skills in the convergence of life sciences, engineering, and computational & data science, and entrepreneurship, to advance innovation in biomedical field. BIOTIN is coordinated by Izmir Institute of Technology (IZTECH) in collaboration with two implementing partners: Boğaziçi University (BOUN) and Izmir Biomedicine and Genome Center (IBG). A total of 28 associated partner organisations (17 academic and 11 non-academic) is contributing to the program. The program offers interdisciplinary, intersectoral, and international mobility opportunities by bringing together academic and industry institutions, research centers and technology-driven startups around the world. It also provides fellows opportunities to work on cutting-edge research projects along with personalized career development plans focusing on developing scientific expertise, transferable skills, and professional competencies. BIOTIN program will generate highly-skilled, innovation-minded experts who can address complex biomedical challenges, leading to the development of startups, patents, and innovations in the field of biomedical sciences and technologies. Thus, BIOTIN will not only contribute to improved employability and career development for the DCs, it will also contribute to increased innovation and entrepreneurship in biomedical field and competitiveness of the EU in research and innovation.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Spinning discoveries out of research institutions requires expertise and ecosystem that is hard to bring together in the academic environment. One of the main challenges is the lack of qualified personnel having multidisciplinary technical skills endowed with transferrable skills. Biomedical Technologies and Innovation (BIOTIN) doctoral programme features an international, interdisciplinary and intersectoral approach to provide 10 doctoral candidates (DCs) a unique blend of research training skills in the convergence of life sciences, engineering, and computational & data science, and entrepreneurship skills, with the aim of advancing innovation in biomedical research and education. The BIOTIN programme will address the challenges in three intertwined themes of biomedical research: drug discovery and development, diagnosis, tissue engineering and regeneration, by leveraging latest developments in data science and machine learning. BIOTIN is presented and coordinated by Izmir Institute of Technology (IZTECH) in collaboration with two implementing partners: Bogazici University (BOUN) and Izmir Biomedicine and Genome Center (IBG). A total of 22 associated partner organisations including 11 academic and 11 non-academic organisations will contribute to the programme. BIOTIN fellows will benefit from a highly-qualified interdisciplinary supervisory team, secondment-and short-visits to network partners in Europe and beyond including prominent universities, NGO (Istanbul Health Industry Cluster), large enterprises (e.g. Siemenes Healthineers and Amgen) and start-ups, alongside the opportunity to develop and practice entrepreneurship skills in leading technology development zones of Turkey.The consortium will build a group of researchers with a valuable and rare blend of academic skills and industry readiness, who in return can fulfil regional, national and international human resources needs in biomedical research far beyond the funding period.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз